Quick Heal Technologies Limited
NSE:QUICKHEAL.NS
655.4 (INR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,917.5 | 2,780.9 | 3,419 | 3,330.44 | 2,861.38 | 3,149.26 | 3,183.15 | 2,999.73 | 3,380.696 | 2,861.155 | 2,428.38 | 2,050.05 |
| Cost of Revenue
| 1,884.6 | 93.3 | 1,498.3 | 191.08 | 182.87 | 225.55 | 270.48 | 373.97 | 429.515 | 403.265 | 201.93 | 149.42 |
| Gross Profit
| 1,032.9 | 2,687.6 | 1,920.7 | 3,139.36 | 2,678.51 | 2,923.71 | 2,912.67 | 2,625.76 | 2,951.181 | 2,457.89 | 2,226.45 | 1,900.63 |
| Gross Profit Ratio
| 0.354 | 0.966 | 0.562 | 0.943 | 0.936 | 0.928 | 0.915 | 0.875 | 0.873 | 0.859 | 0.917 | 0.927 |
| Reseach & Development Expenses
| 1,331 | 1,213.1 | 897.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 271.4 | 156.1 | 101.43 | 106.6 | 67.8 | 83.75 | 148.03 | 83.589 | 31.078 | 178.54 | 98.77 |
| Selling & Marketing Expenses
| 0 | 347.8 | 282.4 | 233.13 | 319.89 | 303.52 | 307.86 | 215.82 | 691.736 | 654.447 | 487.22 | 383.49 |
| SG&A
| 983.4 | 619.2 | 438.5 | 334.56 | 426.49 | 371.32 | 391.61 | 363.85 | 775.325 | 685.525 | 1,161.9 | 814.66 |
| Other Expenses
| 213.9 | 221.3 | 35.5 | 49.82 | 65.6 | 28.86 | 85.33 | 17.33 | 10.039 | 0.511 | 0 | 0 |
| Operating Expenses
| 983.4 | 2,828.7 | 1,024.2 | 1,883.16 | 1,978.99 | 1,876.1 | 1,974.61 | 2,028.35 | 2,161.526 | 1,735.609 | 1,446.12 | 876.18 |
| Operating Income
| 49.5 | -98.2 | 904.2 | 1,221.2 | 698.24 | 1,047.61 | 938.06 | 597.41 | 789.655 | 722.281 | 938.41 | 1,013.44 |
| Operating Income Ratio
| 0.017 | -0.035 | 0.264 | 0.367 | 0.244 | 0.333 | 0.295 | 0.199 | 0.234 | 0.252 | 0.386 | 0.494 |
| Total Other Income Expenses Net
| 212.6 | 178.4 | 182.6 | 240.1 | 314.87 | 322.58 | 296.1 | 241.3 | 95.917 | 75.975 | -78.13 | 91.28 |
| Income Before Tax
| 262.1 | 80.2 | 1,086.8 | 1,461.37 | 1,013.11 | 1,370.19 | 1,234.16 | 838.71 | 885.572 | 798.256 | 860.28 | 1,104.72 |
| Income Before Tax Ratio
| 0.09 | 0.029 | 0.318 | 0.439 | 0.354 | 0.435 | 0.388 | 0.28 | 0.262 | 0.279 | 0.354 | 0.539 |
| Income Tax Expense
| 19.7 | 16.2 | 254.9 | 391.57 | 269 | 451.95 | 404.11 | 306.44 | 301.575 | 260.212 | 276.46 | 335.73 |
| Net Income
| 242.4 | 64 | 831.9 | 1,069.7 | 744.11 | 918.24 | 830.05 | 532.27 | 583.997 | 538.044 | 583.82 | 768.99 |
| Net Income Ratio
| 0.083 | 0.023 | 0.243 | 0.321 | 0.26 | 0.292 | 0.261 | 0.177 | 0.173 | 0.188 | 0.24 | 0.375 |
| EPS
| 4.56 | 1.14 | 14.01 | 16.66 | 11.34 | 13.03 | 11.82 | 7.6 | 9.29 | 8.81 | 9.43 | 12.59 |
| EPS Diluted
| 4.48 | 1.14 | 13.94 | 16.65 | 11.34 | 13.02 | 11.79 | 7.55 | 9.27 | 8.69 | 9.43 | 12.59 |
| EBITDA
| 175.5 | 18.8 | 953 | 1,365.37 | 818.72 | 1,248.91 | 1,203.44 | 925.92 | 1,009.556 | 913.071 | 1,046.56 | 1,057.83 |
| EBITDA Ratio
| 0.06 | 0.007 | 0.279 | 0.41 | 0.286 | 0.397 | 0.378 | 0.309 | 0.299 | 0.319 | 0.431 | 0.516 |